期刊
IMMUNOLOGICAL REVIEWS
卷 274, 期 1, 页码 290-306出版社
WILEY
DOI: 10.1111/imr.12464
关键词
B cells; complement system; dendritic cells; macrophages; myeloid-derived suppressor cells; natural killer cells; STING
类别
资金
- Foundation for Applied Medical Research (FIMA)
- Red Tematica de Investigacion Cooperativa en Cancer [RD12/0036/0040, RD12/0036/0062]
- Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (FEDER) [PI14/01686, PI13/00207]
- FAECC
- H2020 PROCROP project [635122]
- Instituto de Salud Carlos III [CPII15/00004]
Chronic inflammation in the tumor microenvironment and evasion of the antitumor effector immune response are two of the emerging hallmarks required for oncogenesis and cancer progression. The innate immune system not only plays a critical role in perpetuating these tumor-promoting hallmarks but also in developing antitumor adaptive immune responses. Thus, understanding the dual role of the innate system in cancer immunology is required for the design of combined immunotherapy strategies able to tackle established tumors. Here, we review recent advances in the understanding of the role of cell populations and soluble components of the innate immune system in cancer, with a focus on complement, the adapter molecule Stimulator of Interferon Genes, natural killer cells, myeloid cells, and B cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据